Literature DB >> 28266322

Obesity-related, metabolic asthma: a new role for glucagon-like peptide 1 agonists.

Dan-Vinh Nguyen1, Angela Linderholm2, Angela Haczku2, Nicholas Kenyon2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28266322      PMCID： PMC8908331          DOI： 10.1016/S2213-2600(17)30051-6

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN： 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  14 in total

Review 1.  Metabolic Syndrome and the Lung.

Authors:  Cynthia W Baffi; Lisa Wood; Daniel Winnica; Patrick J Strollo; Mark T Gladwin; Loretta G Que; Fernando Holguin
Journal:  Chest       Date:  2016-01-20       Impact factor: 9.410

2.  Increased levels of HMGB-1 and endogenous secretory RAGE in induced sputum from asthmatic patients.

Authors:  Tetsuya Watanabe; Kazuhisa Asai; Hiroki Fujimoto; Hidenori Tanaka; Hiroshi Kanazawa; Kazuto Hirata
Journal:  Respir Med       Date:  2010-10-30       Impact factor: 3.415

3.  Glucagon-Like Peptide 1 Receptor: A Novel Pharmacological Target for Treating Human Bronchial Hyperresponsiveness.

Authors:  Paola Rogliani; Luigino Calzetta; Barbara Capuani; Francesco Facciolo; Mario Cazzola; Davide Lauro; Maria Gabriella Matera
Journal:  Am J Respir Cell Mol Biol       Date:  2016-12       Impact factor: 6.914

4.  Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression.

Authors:  Ayako Ojima; Yuji Ishibashi; Takanori Matsui; Sayaka Maeda; Yuri Nishino; Masayoshi Takeuchi; Kei Fukami; Sho-ichi Yamagishi
Journal:  Am J Pathol       Date:  2012-11-14       Impact factor: 4.307

5.  GLP-1 stimulates secretion of macromolecules from airways and relaxes pulmonary artery.

Authors:  G Richter; O Feddersen; U Wagner; P Barth; R Göke; B Göke
Journal:  Am J Physiol       Date:  1993-10

6.  The receptor for advanced glycation end products is a central mediator of asthma pathogenesis.

Authors:  Pavle S Milutinovic; John F Alcorn; Judson M Englert; Lauren T Crum; Tim D Oury
Journal:  Am J Pathol       Date:  2012-08-11       Impact factor: 4.307

7.  The receptor for advanced glycation end products is required for β-catenin stabilization in a chemical-induced asthma model.

Authors:  Lihong Yao; Haijin Zhao; Haixiong Tang; Junjie Liang; Laiyu Liu; Hangming Dong; Fei Zou; Shaoxi Cai
Journal:  Br J Pharmacol       Date:  2016-07-27       Impact factor: 8.739

8.  Metabolic Syndrome Is Associated with Increased Oxo-Nitrative Stress and Asthma-Like Changes in Lungs.

Authors:  Vijay Pal Singh; Rangoli Aggarwal; Suchita Singh; Arpita Banik; Tanveer Ahmad; Bijay Ranjan Patnaik; Giridharan Nappanveettil; Kunal Pratap Singh; Madan Lal Aggarwal; Balaram Ghosh; Anurag Agrawal
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

9.  Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

Authors:  Steven P Marso; Gilbert H Daniels; Kirstine Brown-Frandsen; Peter Kristensen; Johannes F E Mann; Michael A Nauck; Steven E Nissen; Stuart Pocock; Neil R Poulter; Lasse S Ravn; William M Steinberg; Mette Stockner; Bernard Zinman; Richard M Bergenstal; John B Buse
Journal:  N Engl J Med       Date:  2016-06-13       Impact factor: 176.079

10.  Glucagon Like Peptide-1 (GLP-1) Modulates OVA-Induced Airway Inflammation and Mucus Secretion Involving a Protein Kinase A (PKA)-Dependent Nuclear Factor-κB (NF-κB) Signaling Pathway in Mice.

Authors:  Tao Zhu; Xiao-Ling Wu; Wei Zhang; Min Xiao
Journal:  Int J Mol Sci       Date:  2015-08-26       Impact factor: 5.923
View more
  2 in total

Review 1.  Beneficial Influence of Exendin-4 on Specific Organs and Mechanisms Favourable for the Elderly with Concomitant Obstructive Lung Diseases.

Authors:  Magdalena Figat; Grzegorz Kardas; Piotr Kuna; Michał G Panek
Journal:  Brain Sci       Date:  2022-08-17

2.  Circulating Levels of the Soluble Receptor for AGE (sRAGE) during Escalating Oral Glucose Dosages and Corresponding Isoglycaemic i.v. Glucose Infusions in Individuals with and without Type 2 Diabetes.

Authors:  Amelia K Fotheringham; Jonatan I Bagger; Danielle J Borg; Domenica A McCarthy; Jens J Holst; Tina Vilsbøll; Filip K Knop; Josephine M Forbes
Journal:  Nutrients       Date:  2020-09-24       Impact factor: 5.717
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.